Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05308290 · ClinicalTrials.gov registry record · NA
Optimizing Cerebral Autoregulation During Surgery
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT05308290: Completed NA study, sponsored by Johns Hopkins University.
NCT05308290 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05308290, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a pilot trial to determine the feasibility, safety, and potential efficacy of targeting mean arterial blood pressure (MAP) within the limits of cerebral autoregulation during surgery compared with usual care.
Interventions
- OTHER Blood pressure management according to cerebral autoregulation
- OTHER Blood pressure management according to usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05308290
The ClinicalTrials.gov registry entry for NCT05308290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood pressure management according to cerebral autoregulation is the first listed.
NCT05308290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05308290 about?
NCT05308290 is a clinical study titled "Optimizing Cerebral Autoregulation During Surgery". The purpose of this study is to conduct a pilot trial to determine the feasibility, safety, and potential efficacy of targeting mean arterial blood pressure (MAP) within the limits of cerebral autoregulation during surgery compared with usual care.
What is the current status of trial NCT05308290?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2023-01-09. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT05308290?
The interventions under investigation include: Blood pressure management according to cerebral autoregulation (OTHER), Blood pressure management according to usual care (OTHER).
Who is sponsoring clinical trial NCT05308290?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.